Portfolio Holdings Detail for ISIN IE00BYXG2H39
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | BTEC(USD) LSE |
| ETF Ticker | BTEK(GBP) LSE |
| ETF Ticker | 2B70(EUR) F |
| ETF Ticker | 2B70.DE(EUR) CXE |
| ETF Ticker | BTEC.LS(USD) CXE |
| ETF Ticker | BTEK.LS(GBP) CXE |
| ETF Ticker | BTEC.L(GBP) LSE |
| ETF Ticker | BTEK.L(GBP) LSE |
Holdings detail for PRAX
| Stock Name | Praxis Precision Medicines Inc |
| Ticker | PRAX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US74006W1080 |
Show aggregate PRAX holdings
News associated with PRAX
- Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year Low After Analyst Downgrade
- Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) reached a new 52-week low during trading on Tuesday after Wedbush downgraded the stock from a hold rating to a strong sell rating. The stock traded as low as $30.01 and last traded at $32.63, with a volume of 94961 shares traded. The stock […] - 2025-03-06 07:08:14
- New York State Common Retirement Fund Has $604,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)
- New York State Common Retirement Fund raised its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 12.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 7,847 shares of the company’s stock after buying an additional 847 shares during the period. New York State […] - 2025-03-05 11:01:03
- Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock Holdings Decreased by Rhumbline Advisers
- Rhumbline Advisers decreased its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,769 shares of the company’s stock after selling 347 shares during the period. Rhumbline Advisers’ holdings in Praxis Precision […] - 2025-03-05 10:08:59
- HC Wainwright Has Lowered Expectations for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price
- Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective decreased by stock analysts at HC Wainwright from $120.00 to $105.00 in a report released on Monday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective would suggest a potential upside of 189.98% from the […] - 2025-03-05 07:04:58
- Needham & Company LLC Lowers Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $85.00
- Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price target cut by investment analysts at Needham & Company LLC from $150.00 to $85.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective indicates a […] - 2025-03-05 07:04:55
- Truist Financial Cuts Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $85.00
- Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Truist Financial from $175.00 to $85.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research analysts have also issued reports on PRAX. Needham & Company LLC cut their target […] - 2025-03-04 06:52:56
- Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $145.20 Average Target Price from Brokerages
- Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the ten research firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month […] - 2025-02-26 06:23:00
- Deutsche Bank Aktiengesellschaft Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)
- Deutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $111.00 price target on the stock. A number of other research firms have also commented on PRAX. Oppenheimer increased their […] - 2025-02-14 08:32:53
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) PRAX holdings
| Date | Number of PRAX Shares Held | Base Market Value of PRAX Shares | Local Market Value of PRAX Shares | Change in PRAX Shares Held | Change in PRAX Base Value | Current Price per PRAX Share Held | Previous Price per PRAX Share Held |
|---|
| 2025-03-11 (Tuesday) | 9,193 | USD 345,657 | USD 345,657 | 0 | USD 12,778 | USD 37.6 | USD 36.2101 |
| 2025-03-10 (Monday) | 9,193 | USD 332,879 | USD 332,879 | 0 | USD -21,052 | USD 36.2101 | USD 38.5001 |
| 2025-03-07 (Friday) | 9,193 | USD 353,931 | USD 353,931 | -60 | USD 3,520 | USD 38.5001 | USD 37.87 |
| 2025-03-06 (Thursday) | 9,253 | USD 350,411 | USD 350,411 | 0 | USD 185 | USD 37.87 | USD 37.85 |
| 2025-03-05 (Wednesday) | 9,253 | USD 350,226 | USD 350,226 | 0 | USD 15,175 | USD 37.85 | USD 36.21 |
| 2025-03-04 (Tuesday) | 9,253 | USD 335,051 | USD 335,051 | -30 | USD 23,606 | USD 36.21 | USD 33.55 |
| 2025-03-03 (Monday) | 9,283 | USD 311,445 | USD 311,445 | 0 | USD -46,879 | USD 33.55 | USD 38.6 |
| 2025-02-28 (Friday) | 9,283 | USD 358,324 | USD 358,324 | 0 | USD -245,349 | USD 38.6 | USD 65.0299 |
| 2025-02-27 (Thursday) | 9,283 | USD 603,673 | USD 603,673 | 0 | USD -31,191 | USD 65.0299 | USD 68.39 |
| 2025-02-26 (Wednesday) | 9,283 | USD 634,864 | USD 634,864 | 0 | USD 13,924 | USD 68.39 | USD 66.89 |
| 2025-02-25 (Tuesday) | 9,283 | USD 620,940 | USD 620,940 | 58 | USD 5,540 | USD 66.89 | USD 66.71 |
| 2025-02-24 (Monday) | 9,225 | USD 615,400 | USD 615,400 | 0 | USD -71,770 | USD 66.71 | USD 74.49 |
| 2025-02-21 (Friday) | 9,225 | USD 687,170 | USD 687,170 | 0 | USD -46,587 | USD 74.49 | USD 79.5401 |
| 2025-02-20 (Thursday) | 9,225 | USD 733,757 | USD 733,757 | 0 | USD -14,206 | USD 79.5401 | USD 81.08 |
| 2025-02-19 (Wednesday) | 9,225 | USD 747,963 | USD 747,963 | -29 | USD 20,136 | USD 81.08 | USD 78.65 |
| 2025-02-18 (Tuesday) | 9,254 | USD 727,827 | USD 727,827 | 0 | USD -112,159 | USD 78.65 | USD 90.77 |
| 2025-02-17 (Monday) | 9,254 | USD 839,986 | USD 839,986 | 0 | USD 0 | USD 90.77 | USD 90.77 |
| 2025-02-14 (Friday) | 9,254 | USD 839,986 | USD 839,986 | 0 | USD 38,034 | USD 90.77 | USD 86.66 |
| 2025-02-13 (Thursday) | 9,254 | USD 801,952 | USD 801,952 | 87 | USD 19,090 | USD 86.66 | USD 85.4 |
| 2025-02-12 (Wednesday) | 9,167 | USD 782,862 | USD 782,862 | 29 | USD 13,077 | USD 85.4 | USD 84.24 |
| 2025-02-11 (Tuesday) | 9,138 | USD 769,785 | USD 769,785 | 116 | USD 4,268 | USD 84.24 | USD 84.85 |
| 2025-02-10 (Monday) | 9,022 | USD 765,517 | USD 765,517 | 0 | USD -18,314 | USD 84.85 | USD 86.88 |
| 2025-02-07 (Friday) | 9,022 | USD 783,831 | USD 783,831 | 0 | USD -4,782 | USD 86.88 | USD 87.41 |
| 2025-02-06 (Thursday) | 9,022 | USD 788,613 | USD 788,613 | 0 | USD -7,398 | USD 87.41 | USD 88.23 |
| 2025-02-05 (Wednesday) | 9,022 | USD 796,011 | USD 796,011 | 0 | USD 42,764 | USD 88.23 | USD 83.49 |
| 2025-02-04 (Tuesday) | 9,022 | USD 753,247 | USD 753,247 | 0 | USD 29,141 | USD 83.49 | USD 80.26 |
| 2025-02-03 (Monday) | 9,022 | USD 724,106 | USD 724,106 | 0 | USD 33,472 | USD 80.26 | USD 76.55 |
| 2025-01-31 (Friday) | 9,022 | USD 690,634 | USD 690,634 | 0 | USD 3,158 | USD 76.55 | USD 76.2 |
| 2025-01-30 (Thursday) | 9,022 | USD 687,476 | USD 687,476 | 0 | USD 19,668 | USD 76.2 | USD 74.02 |
| 2025-01-29 (Wednesday) | 9,022 | USD 667,808 | USD 667,808 | 0 | USD -12,090 | USD 74.02 | USD 75.36 |
| 2025-01-28 (Tuesday) | 9,022 | USD 679,898 | USD 679,898 | 0 | USD 18,585 | USD 75.36 | USD 73.3 |
| 2025-01-27 (Monday) | 9,022 | USD 661,313 | USD 661,313 | 0 | USD -34,373 | USD 73.3 | USD 77.11 |
| 2025-01-24 (Friday) | 9,022 | USD 695,686 | USD 695,686 | 0 | USD -4,421 | USD 77.11 | USD 77.6 |
| 2025-01-23 (Thursday) | 9,022 | USD 700,107 | USD 700,107 | 0 | USD -17,954 | USD 77.6 | USD 79.59 |
| 2025-01-22 (Wednesday) | 9,022 | USD 718,061 | USD 718,061 | | | | |
| 2025-01-21 (Tuesday) | 9,022 | USD 706,062 | USD 706,062 | | | | |
| 2025-01-20 (Monday) | 9,022 | USD 636,412 | USD 636,412 | | | | |
| 2025-01-17 (Friday) | 9,022 | USD 636,412 | USD 636,412 | | | | |
| 2025-01-16 (Thursday) | 8,906 | USD 625,647 | USD 625,647 | | | | |
| 2025-01-15 (Wednesday) | 8,790 | USD 611,696 | USD 611,696 | | | | |
| 2025-01-14 (Tuesday) | 8,790 | USD 578,734 | USD 578,734 | | | | |
| 2025-01-13 (Monday) | 8,790 | USD 562,736 | USD 562,736 | | | | |
| 2025-01-10 (Friday) | 8,790 | USD 555,089 | USD 555,089 | | | | |
| 2025-01-09 (Thursday) | 8,848 | USD 651,921 | USD 651,921 | | | | |
| 2025-01-09 (Thursday) | 8,848 | USD 651,921 | USD 651,921 | | | | |
| 2025-01-09 (Thursday) | 8,848 | USD 651,921 | USD 651,921 | | | | |
| 2025-01-08 (Wednesday) | 8,848 | USD 651,921 | USD 651,921 | | | | |
| 2025-01-08 (Wednesday) | 8,848 | USD 651,921 | USD 651,921 | | | | |
| 2025-01-08 (Wednesday) | 8,848 | USD 651,921 | USD 651,921 | | | | |
| 2025-01-02 (Thursday) | 8,964 | USD 712,817 | USD 712,817 | | | | |
| 2024-12-30 (Monday) | 8,964 | USD 683,595 | USD 683,595 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of PRAX by Blackrock for IE00BYXG2H39
Show aggregate share trades of PRAX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-03-07 | SELL | -60 | | | 38.500* | | 72.39 Profit of 4,343 on sale |
| 2025-03-04 | SELL | -30 | | | 36.210* | | 76.14 Profit of 2,284 on sale |
| 2025-02-25 | BUY | 58 | | | 66.890* | | 80.85 |
| 2025-02-19 | SELL | -29 | | | 81.080* | | 81.99 Profit of 2,378 on sale |
| 2025-02-13 | BUY | 87 | | | 86.660* | | 80.73 |
| 2025-02-12 | BUY | 29 | | | 85.400* | | 80.39 |
| 2025-02-11 | BUY | 116 | | | 84.240* | | 80.10 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of PRAX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-12 | 78,065 | 0 | 231,208 | 33.8% |
| 2025-03-11 | 107,030 | 194 | 164,213 | 65.2% |
| 2025-03-10 | 249,786 | 239 | 338,818 | 73.7% |
| 2025-03-07 | 198,989 | 76 | 398,402 | 49.9% |
| 2025-03-06 | 126,797 | 93 | 314,642 | 40.3% |
| 2025-03-05 | 143,622 | 3,152 | 222,956 | 64.4% |
| 2025-03-04 | 190,268 | 3,820 | 414,403 | 45.9% |
| 2025-03-03 | 149,871 | 6,640 | 431,719 | 34.7% |
| 2025-02-28 | 370,736 | 40,195 | 1,530,266 | 24.2% |
| 2025-02-27 | 48,133 | 0 | 81,273 | 59.2% |
| 2025-02-26 | 43,748 | 0 | 99,021 | 44.2% |
| 2025-02-25 | 51,816 | 121 | 137,214 | 37.8% |
| 2025-02-24 | 98,733 | 885 | 268,376 | 36.8% |
| 2025-02-21 | 76,002 | 12 | 182,146 | 41.7% |
| 2025-02-20 | 36,960 | 4 | 140,744 | 26.3% |
| 2025-02-19 | 48,558 | 1,611 | 185,805 | 26.1% |
| 2025-02-18 | 106,901 | 1,952 | 242,326 | 44.1% |
| 2025-02-14 | 96,017 | 1,163 | 319,999 | 30.0% |
| 2025-02-13 | 66,328 | 18 | 242,492 | 27.4% |
| 2025-02-12 | 52,439 | 10 | 122,697 | 42.7% |
| 2025-02-11 | 101,575 | 0 | 136,021 | 74.7% |
| 2025-02-10 | 55,238 | 157 | 130,771 | 42.2% |
| 2025-02-07 | 64,665 | 154 | 203,565 | 31.8% |
| 2025-02-06 | 42,212 | 0 | 122,029 | 34.6% |
| 2025-02-05 | 33,738 | 0 | 143,992 | 23.4% |
| 2025-02-04 | 75,611 | 4 | 171,172 | 44.2% |
| 2025-02-03 | 57,701 | 0 | 176,106 | 32.8% |
| 2025-01-31 | 78,642 | 52 | 129,221 | 60.9% |
| 2025-01-30 | 145,249 | 7 | 188,467 | 77.1% |
| 2025-01-29 | 28,018 | 0 | 45,480 | 61.6% |
| 2025-01-28 | 37,359 | 0 | 56,974 | 65.6% |
| 2025-01-27 | 96,077 | 0 | 206,184 | 46.6% |
| 2025-01-24 | 193,388 | 61 | 241,564 | 80.1% |
| 2025-01-23 | 59,260 | 0 | 98,092 | 60.4% |
| 2025-01-22 | 157,618 | 41 | 278,496 | 56.6% |
| 2025-01-21 | 81,572 | 0 | 254,063 | 32.1% |
| 2025-01-17 | 61,459 | 0 | 163,107 | 37.7% |
| 2025-01-16 | 45,786 | 0 | 84,893 | 53.9% |
| 2025-01-15 | 50,235 | 0 | 185,787 | 27.0% |
| 2025-01-14 | 99,543 | 9 | 128,810 | 77.3% |
| 2025-01-13 | 42,260 | 1,913 | 103,390 | 40.9% |
| 2025-01-10 | 119,220 | 192 | 220,118 | 54.2% |
| 2025-01-08 | 35,049 | 52 | 78,819 | 44.5% |
| 2025-01-07 | 50,046 | 0 | 97,547 | 51.3% |
| 2025-01-06 | 27,135 | 0 | 73,681 | 36.8% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.